Studies on Mechanism of Neurotoxicity caused by Methylmercury

甲基汞神经毒性机制研究

基本信息

  • 批准号:
    62480169
  • 负责人:
  • 金额:
    $ 3.9万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1987
  • 资助国家:
    日本
  • 起止时间:
    1987 至 1989
  • 项目状态:
    已结题

项目摘要

In this study, the pharmacokinetics of methylmercury(MM) in rat and its effects on brain mitochondria of rats with the subacute toxicity caused by oral methylmercury chloride administration were investigated.Oral administration of methylmercury chloride to rat by a stomach tube for 7days at a daily dose of 7.0-8.5mg (as Hg/kg rat weight) induced toxicity symptoms of paralysis and hind limb ataxia.The results revealed that MM is tightly bound to haemoglobin in the blood. Moreover a possibility was suggested that the MM in the blood formed a complex with the sulfhydryl group of glutathione(GSH), namely GSH-MM complex, and which is then transferred to several organs. It was also suggested that lipid-soluble MM is related with the translocation into the brain,the accumulation in the brain and the excretion from the brain. The effects of MM on sitochondrial respiration in vitro and in vivo was also studied. In vitro,it was indicated that MM reversely inhibited,the process of oxidative phosphorylation, and that the inhibitory site was located in the electron transfer chain between flavin and cytochrome c_1. In vivo,the MM inhibition on the mitochondria was not observed remarkably,however,lipid peroxidation might occur in the synaptosomal fraction.This study evidently showed that orally administered MM has several biochemical effects on the cellular level.
在本研究中,本文研究了氯化甲基汞(methylmercury,MM)在大鼠体内的药代动力学及其对大鼠脑线粒体的影响。大鼠经胃管灌胃氯化甲基汞7.0-8.5mg,连续7天结果表明,MM与血液中的血红蛋白紧密结合。此外,还提出了一种可能性,即血液中的MM与谷胱甘肽(GSH)的巯基形成复合物,即GSH-MM复合物,然后转移到多个器官。脂溶性MM与其在脑内的转运、蓄积和排泄有关。本文还研究了MM在体内外对线粒体呼吸的影响。在体外实验中,MM-1抑制氧化磷酸化过程,其抑制部位位于黄素与细胞色素c_1之间的电子传递链上。在体内,MM对线粒体的抑制作用不明显,但在突触体部分可能发生脂质过氧化反应,这表明口服MM在细胞水平上具有多种生化作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FUJIKI Motoo其他文献

FUJIKI Motoo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Regulatory mechanism of intestinal inflammation via promotion of regulatory T cell differentiation by oral administration of Lactobacillus
口服乳酸菌促进调节性T细胞分化调节肠道炎症的机制
  • 批准号:
    23H02160
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Evaluation of oral administration of PRIM-DJ2727 capsule containing microbiota suspension in patients with severe alcoholic hepatitis: An Open-Label Study
严重酒精性肝炎患者口服含有微生物悬浮液的 PRIM-DJ2727 胶囊的评价:一项开放标签研究
  • 批准号:
    10527603
  • 财政年份:
    2022
  • 资助金额:
    $ 3.9万
  • 项目类别:
A Novel Probiotic Drug Delivery Platform for Oral Administration of Protein-Based Therapies
用于口服蛋白质疗法的新型益生菌药物递送平台
  • 批准号:
    10544376
  • 财政年份:
    2022
  • 资助金额:
    $ 3.9万
  • 项目类别:
Evaluation of oral administration of PRIM-DJ2727 capsule containing microbiota suspension in patients with severe alcoholic hepatitis: An Open-Label Study
严重酒精性肝炎患者口服含有微生物悬浮液的 PRIM-DJ2727 胶囊的评价:一项开放标签研究
  • 批准号:
    10686094
  • 财政年份:
    2022
  • 资助金额:
    $ 3.9万
  • 项目类别:
Oral Administration of Reoviruses for the Treatment, Prevention and Early Diagnosis of Colorectal Cancer.
口服呼肠孤病毒用于治疗、预防和早期诊断结直肠癌。
  • 批准号:
    453445
  • 财政年份:
    2021
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Operating Grants
Improvement of alcohol-poisoning symptoms in mice by the oral administration of live Lactobacillus plantarum SN13T cells
口服活植物乳杆菌SN13T细胞改善小鼠酒精中毒症状
  • 批准号:
    20K11510
  • 财政年份:
    2020
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of novel prodrug-type polymeric micelles for targeting systemic cancers by oral administration
开发新型前药型聚合物胶束,用于口服靶向全身癌症
  • 批准号:
    19K20702
  • 财政年份:
    2019
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Investigating brain penetrance after oral administration of novel cannabinoid extracts in mice
研究小鼠口服新型大麻素提取物后的脑外显率
  • 批准号:
    538283-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Engage Grants Program
Effect of oral administration of phytochemicals on bone formation at tooth extraction sockets in an osteoporotic animal model
口服植物化学物质对骨质疏松动物模型拔牙槽骨形成的影响
  • 批准号:
    19K24135
  • 财政年份:
    2019
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Investigation of suppressive effects on food allergy and type 1 diabetes by means of oral administration of oral bacteria.
通过口服口腔细菌来研究对食物过敏和 1 型糖尿病的抑制效果。
  • 批准号:
    19K10096
  • 财政年份:
    2019
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了